Evidence for tumor immunity in human malignant melanoma
Nagel, G.A.
Schweizerische Medizinische Wochenschrift 100(23): 995-1000
1970
ISSN/ISBN: 0036-7672 PMID: 4947017 Document Number: 26227
Document emailed within 1 workday
Related Documents
Arlen, M.; Hollinshead, A.; Scherrer, J. 1977: Tumor-specific immunity in patients with malignant melanoma Surgical Forum 28: 168-169Robertson, G.; Coleman, A.; Lugo, T.G. 1996: A malignant melanoma tumor suppressor on human chromosome 11 Cancer Research 56(19): 4487-4492
Bogdahn, U.; Apfel, R.; Hahn, M.; Gerlach, M.; Behl, C.; Hoppe, J.; Martin, R. 1989: Autocrine tumor cell growth-inhibiting activities from human malignant melanoma Cancer Research 49(19): 5358-5363
Shibata, S.; Ochi, A.; Yamashita, H.; Yasunaga, A.; Mori, K. 1990: Ultrastructure of capillary permeability in human brain tumor: primary meningeal malignant melanoma No Shinkei Geka. Neurological Surgery 18(6): 527-531
Kiyohara, Y.; Yoshikawa, S.; Fujiwara, N.; Otsuka, M.; Nakagawa, M.; Yamamoto, A.; Saida, T. 2005: Sentinel node navigation surgery in melanoma and non-melanoma malignant skin tumor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(8): 1191-1194
Pantazis, P.; Hinz, H.R.; Mendoza, J.T.; Kozielski, A.J.; Williams, L.J.; Stehlin, J.S.; Giovanella, B.C. 1992: Complete inhibition of growth followed by death of human malignant melanoma cells in vitro and regression of human melanoma xenografts in immunodeficient mice induced by camptothecins Cancer Research 52(14): 3980-3987
Miura, T.; Ishikawa, S. 1970: Malignant melanoma--synopses from the seminar on malignant melanoma by International Group for the Clinical Study of Melanoma Gan no Rinsho. Japan Journal of Cancer Clinics 16(11): 1064-1070
Glinkina, L.S.; Bruvere, R.Z.; Venskus, D.R.; Garklava, R.R.; Muceniece, A.J. 1992: The cellular immunity indices of patients with malignant melanoma using the viral immunomodulator rigvir Voprosy Onkologii 38(5): 540-547
Winter, M.; Nelson, D.S.; Milton, G.W. 1980: Leucocyte adherence inhibition test for the detection of cell-mediated immunity to malignant melanoma Australian and New Zealand Journal of Medicine 10(4): 405-409
Munzarová, M.; Mechl, Z.; Rejthar, A.; Kolcová, V. 1990: Multinucleated tumor cells and malignant melanoma Neoplasma 37(6): 711-716
Seregard, S.; Kock, E. 1993: Malignant melanoma of the conjunctiva. it is important to know about this unusual tumor Lakartidningen 90(7): 575-576
Nairn, R.C.; Nind, A.P.; Guli, E.P.; Davies, D.J.; Little, J.H.; Davis, N.C.; Whitehead, R.H. 1972: Anti-tumor immunoreactivity in patients with malignant melanoma Medical Journal of Australia 1(9): 397-403
Olson, J.L.; Philips, T.M.; Lewis, M.G.; Solez, K. 1979: Malignant melanoma with renal dense deposits containing tumor antigens Clinical Nephrology 12(2): 74-82
Law, L.W.; Vieira, W.D.; Kameyama, K.; Hearing, V.J. 1987: A unique tumor rejection antigen from the S91 murine malignant melanoma Cancer Research 47(22): 5841-5845
Tahara, H.; Zeh, H.J.; Storkus, W.J.; Pappo, I.; Watkins, S.C.; Gubler, U.; Wolf, S.F.; Robbins, P.D.; Lotze, M.T. 1994: Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo Cancer Research 54(1): 182-189
Lee, T.L.; Yang, M.L.; Bell, P.B. 1988: Interaction of B16 malignant melanoma tumor cells with the murine mesentery in vitro Cancer Research 48(18): 5296-5301
2002: Of mice and humans. Updates on susceptibility and tumor suppression of malignant melanoma Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 53(1): 88-89
Dundr, P.; Němejcová, K.ýna.; Bártů, M.; Tichá, I.; Jakša, R. 2018: Evaluation of inflammatory cells (tumor infiltrating lymphocytes - TIL) in malignant melanoma Ceskoslovenska Patologie 54(1): 27-31
McNelis, F.L.; Barone, A.J. 1985: Metastatic malignant melanoma in the mandible. Site is a rare one for the spread of this tumor Rhode Island Medical Journal 68(9): 403-404
Chess, L.; Bock, G.N.; Ungaro, P.C.; Buchholz, D.H.; Mardiney, M.R. 1973: Immunologic effects of BCG in patients with malignant melanoma: specific evidence for stimulation of the 'secondary' immune response Journal of the National Cancer Institute 51(1): 57-65